Related references
Note: Only part of the references are listed.Cancer biology and molecular genetics of A3 adenosine receptor
Chiara Mazziotta et al.
ONCOGENE (2022)
Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects
Hong Zhou et al.
ONCOTARGETS AND THERAPY (2020)
Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib
Elena A. Dmitrieva et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions
Jennifer Series et al.
HAEMATOLOGICA (2019)
Ibrutinib and Venetoclax Doubling Down on CLL
Adrian Wiestner
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CD73: an emerging checkpoint for cancer immunotherapy
Siqi Chen et al.
IMMUNOTHERAPY (2019)
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
Jennifer R. Brown et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
Andrea M. Chambers et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones
Omar Elaskalani et al.
CELL COMMUNICATION AND SIGNALING (2018)
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI
Phillip L. R. Nicolson et al.
HAEMATOLOGICA (2018)
Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development
James J. y Crawford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI
Phillip L. R. Nicolson et al.
HAEMATOLOGICA (2018)
Bone Marrow Defects and Platelet Function: A Focus on MDS and CLL
Sarah Luu et al.
CANCERS (2018)
Potency and Selectivity of BTK Inhibitors in Clinical Development for B-Cell Malignancies
Allard Kaptein et al.
BLOOD (2018)
Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis
Robert H. Lee et al.
HAEMATOLOGICA (2017)
Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis
Robert H. Lee et al.
HAEMATOLOGICA (2017)
Ibrutinib: A Review in Chronic Lymphocytic Leukaemia
Emma D. Deeks
DRUGS (2017)
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment
Roberta Valsecchi et al.
BLOOD (2016)
Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets
Peter M. Benz et al.
CELL COMMUNICATION AND SIGNALING (2016)
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly
Anna Korycka-Wolowiec et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5′-Nucleotidase (CD73) Inhibitors
Sanjay Bhattarai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
S. Kamel et al.
LEUKEMIA (2015)
Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions
Marie Levade et al.
BLOOD (2014)
Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton's Tyrosine Kinase with in Vivo Antitumor Activity
Xitao Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Alterations in Platelet Function During Aging: Clinical Correlations with Thromboinflammatory Disease in Older Adults
Donya Mohebali et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity
S. Cheng et al.
LEUKEMIA (2014)
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Jennifer A. Woyach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
α2β1 Integrin, GPVI Receptor, and Common FcRγ Chain on Mouse Platelets Mediate Distinct Responses to Collagen in Models of Thrombosis
Robin J. Marjoram et al.
PLOS ONE (2014)
Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation
Naadiya Carrim et al.
PLOS ONE (2014)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
Sara Serra et al.
BLOOD (2011)
Adenosine and blood platelets
Hillary A. Johnston-Cox et al.
PURINERGIC SIGNALLING (2011)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia
Dianne Pulte et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Multiple electrode aggregometry:: A new device to measure platelet aggregation in whole blood
Orsolya Toth et al.
THROMBOSIS AND HAEMOSTASIS (2006)
The clinical and epidemiological burden of chronic lymphocytic leukaemia
A Redaelli et al.
EUROPEAN JOURNAL OF CANCER CARE (2004)
Tec regulates platelet activation by GPVI in the absence of Btk
BT Atkinson et al.
BLOOD (2003)
Platelet P-selectin levels in relation to plasma soluble P-selectin and β-thromboglobulin levels in atrial fibrillation
S Kamath et al.
STROKE (2002)
Regulation of platelet aggregation in vitro by plasma adenosine in preeclampsia
T Takeuchi et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2001)
Plasma adenosine levels increase in women with normal pregnancies
Y Yoneyama et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
